New Strategies for Cancer Immunotherapy and Applications of Organ Models
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".
Deadline for manuscript submissions: closed (30 April 2022) | Viewed by 353
Special Issue Editors
Interests: cancer cells; cancer research; oncology;cell culture;cell proliferation;colorectal cancer ;cancer biology;cell signaling;apoptosis;signaling pathways
Special Issues, Collections and Topics in MDPI journals
Interests: cancer therapy;cancer cells;colorectal cancer;tumors;oncology;cancer research; kinase inhibitors;cancer biology
Special Issues, Collections and Topics in MDPI journals
Interests: NSCLC; SCLC; immunotherapy; translational research; EMT; DDR; targeted theraphies; organoids
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue aims to give an updated and translational view on research for cancer focusing on new models for studying new therapies. Recently, the introduction of immunotherapy has completely reshaped the therapeutic approach for many types of cancer with positive results for patients. However, new biomarkers are still needed for improving patients‘ selection; oncology research community is now working on new ex vivo organ models that can recapitulate the complex interaction between cancer and immune cells. We will welcome both original and review articles on this topic.
Dr. Giulia Martini
Dr. Stefania Napolitano
Dr. Carminia Maria Della Corte
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immunotherapy
- organ models
- biomarkers
- translational research
- immunity
